Results 241 to 250 of about 228,145 (411)

BRCA Mutation Testing in Men with Metastatic Castration‐Resistant Prostate Cancer: Practical Guidance for Australian Clinical Practice

open access: yesAsia-Pacific Journal of Clinical Oncology, EarlyView.
Molecular diagnostic testing identified mCRPC patients with BRCA mutations eligible for targeted therapies. Testing success is often contingent on the quality of tissue handling and laboratory processing techniques to minimize DNA degradation and suboptimal sequencing data quality.
Arun A. Azad   +4 more
wiley   +1 more source

Evaluation of dimethandrolone undecanoate in non‐human primates as a candidate for long‐acting injectable male contraceptive

open access: yesAndrology, EarlyView.
Abstract Background Dimethandrolone undecanoate (DMAU) is under development as a single agent hormonal male contraceptive. DMAU is a prodrug hydrolyzed by esterase(s) to the active metabolite dimethandrolone (DMA) which has dual androgenic and progestogenic actions.
Deborah I. Bunin   +11 more
wiley   +1 more source

Mass‐forming intrahepatic cholangiocarcinoma: treatment outcomes after curative‐intent resection in an Australian tertiary referral hospital

open access: yesANZ Journal of Surgery, EarlyView.
The study provides results from 25 years of experience in curative‐intent liver resections for patients with mass‐forming intrahepatic cholangiocarcinoma in Australia. Liver resection can offer a significant chance for prolonged survival, however, the treatment of this rare disease still presents great challenges.
Sander R. W. J. Martens   +5 more
wiley   +1 more source

Pancreatic core biopsies can be obtained with EUS-guided 19G needle systems

open access: bronze, 2001
J.M. Pontes   +4 more
openalex   +1 more source

Underestimation of malignancy of breast core‐needle biopsy [PDF]

open access: bronze, 2006
Nehmat Houssami   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy